Reprint

The Role of Fibrinolytic System in Health and Disease

Edited by
June 2022
170 pages
  • ISBN978-3-0365-4619-3 (Hardback)
  • ISBN978-3-0365-4620-9 (PDF)

This book is a reprint of the Special Issue The Role of Fibrinolytic System in Health and Disease that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

This is a review of the topic of fibrinolysis contributed by authors who are specialized in the clinical and basic studies of this topic. These include: the endothelial receptor of tissue plasminogen activator, by Dr. Katherine Hajjar; regulation of S100 by pml-rar-alpha oncoprotein, by Dr. O’Connell; receptor of urokinase type plasminogen activator, by Dr. M. Ploug et al.; tissue plasminogen activator induction in purjinjen neuron, by Dr. Seeds; fibrinolysis from the blood to the brain, by Dr. Robert Metcalf; tissue plasminogen activator induces the opening of the blood–brain barrier, by Dr. M. Yepes; fibrinolysis shutdown in trauma: a historical review and clinical application, by Drs. Hunter Moore and Ernest Moore; fibrinolysis in immunity, by Drs. K. Kolev and Robert Medcalf; the role of plasminogen activator inhibitor 1, by Drs. M. Erin, A.E. Boe, and E.A. Klyachko; and finally, persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients, by J.P. Meizoso.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
COVID-19; fibrinolysis; renin-aldosterone-angiotensin-system (RAAS); fibrinolysis; plasminogen activator inhibitor 1 (PAI-1); urokinase plasminogen activator; urokinase plasminogen activator receptor; fibrinolysis; plasminogen activator inhibitor-1; acute lung injury and repair and pleural injury and pleural organization; plasminogen activator inhibitor-1; PAI-1; fibrinolysis; cardiovascular disease; cancer; inflammation; fibrosis; aging; obstructive sleep apnoea; OSA; coagulation; fibrinolysis; platelets; urokinase plasminogen activator; brown adipose tissue; obesity; fibrinolysis; plasminogen activation; immune response; inflammation; thrombin activatable fibrinolysis inhibitor; TAFI; coagulation; fibrinolysis; proCPU; proCPB; proCPR; carboxypeptidase; uPA; uPAR; PAI-1; PA system; cancer; tissue-type plasminogen activator (tPA); urokinase-type plasminogen activator (uPA); neurodegeneration; fibrinolysis; thrombin; shear; clot retraction; Factor XIII; clot stability; NETs; platelets; fibrinolysis; plasmin; plasminogen activator; PAI-1; PAI-2; antiplasmin